NEXGEL (NASDAQ:NXGL – Get Free Report) will announce its earnings results before the market opens on Thursday, November 14th.
NEXGEL (NASDAQ:NXGL – Get Free Report) last announced its quarterly earnings results on Monday, August 19th. The company reported ($0.14) earnings per share (EPS) for the quarter. The business had revenue of $1.44 million during the quarter. NEXGEL had a negative net margin of 67.80% and a negative return on equity of 64.21%.
NEXGEL Trading Up 8.0 %
Shares of NEXGEL stock opened at $3.50 on Tuesday. The firm has a market capitalization of $22.13 million, a PE ratio of -6.14 and a beta of 0.73. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.36 and a quick ratio of 0.81. The company’s fifty day moving average price is $2.78 and its two-hundred day moving average price is $2.52. NEXGEL has a 52-week low of $1.70 and a 52-week high of $3.55.
NEXGEL Company Profile
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Further Reading
- Five stocks we like better than NEXGEL
- The How And Why of Investing in Oil Stocks
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What Are the U.K. Market Holidays? How to Invest and Trade
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- How to Find Undervalued Stocks
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.
